Novo Nordisk, the manufacturer of Ozempic, has been facing thousands of lawsuits for allegedly not adequately warning consumers of serious side effects like NAION
Heres the part that complicates it for me: I inject a GLP-1 every week, I own Lilly stock, and I still would not put grey-market retatrutide in my own body
These cases have been consolidated into a federal multidistrict litigation (MDL) in the Eastern District of Pennsylvania, allowing courts to manage the increasing number of claims efficiently
The FDA does not review compounded medications for safety or efficacy
And each test must be performed on people of varying ages (18+), sexes, and skin types.5 In contrast, our picks from The Ordinary, INNBEAUTY Project, and NIOD may have gone through clinical testing, but the safety results are unknown
There has been significant research in recent years focused on the other potential benefits of GLP-1 analogues, many of which could be due to the impact they have on body mass index (BMI) and obesity